Skip to main content

Table 1 Characteristics of included studies

From: Clinical outcomes of nicorandil administration in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials

Study

Year

Onset to reperfusion time, (hours). (N/C)

Sample size (N/C)

Interventions

Followup

Nicorandil

Control

Chen et al. [6]

2015

7.1/7.0

52/52

2 mg ic or 2 mg + anisodamine

2 mg ic

No treatment or anisodamine 2 mg i.c

IH, 30d

Chen et al. [23]

2020

NA

39/39

0.06 mg/kg ic; 2 mg/h iv for 36 h

tirofiban 10 μg/kg ic; 0.1 μg/kg·m iv for 36 h

Tirofiban 10 μg/kg ic

0.1 μg/kg·m iv for 36 h

IH, 30d

Feng et al. [5]

2019

4.7/4.8

90/90

2–6 mg ic; thrombectomy; Tirofiban 10 mg/kg ic

Saline 2–6 mL i.c.; thrombectomy; Tirofiban 10 mg/kg i.c

1,3,6 m

Fukuzawa et al. [9]

2000

4.6/4.5

31/31

4 mg bolus iv, 6 mg/h iv for 24 h

No agent

IH

Ikeda et al. [10]

2004

5.2/5.7

30/30

6 mg/h iv for 72 h, 2 mg ic

Isosorbide dinitrate 6 mg/h iv for 72 h, 2 mg ic

IH

Ishii et al. [11]

2005

4.8/4.5

185/183

12 mg + saline 100 ml iv

isosorbide 2.5-5 mg ic

Saline 100 ml i.v.; isosorbide 2.5-5 mg i.c

2.4y*

Ito et al. [12]

1999

4.8/5.3

40/41

4 mg bolus iv; 6 mg/h for 24 h

15 mg/day po (a mean of 28 days)

No agent

IH

Kitakaze et al. [13]

2007

4.20/4.25

276/269

0.067 mg/kg bolus iv

1∙67 μg/kg.min iv for 24 h

Saline by the same method

 2.5y*

Lee et al. [14]

2008

5.9/5.8

37/36

2 mg ic before CAG

2 mg ic before stenting

No agent

IH;30d

Miyazawa et al. [15]

2006

6.1/8.0

35/35

2 mg ic distal to lesion; 2 mg/h for 24hiv; 15 mg/d po

No agent

8 m

Nameki et al. [16]

2004

5.85/6.17

13/27

4 mg iv 4 mg ic before reperfusion, 4 mg/h iv for 24 h

Magnesium: 10 mmol iv before reperfusion, 0.4 mmol/h for 24 h or no agent

IH;3 m

Ono et al. [17]

2004

5.6/5.1

33/25

4 mg bolus iv, 8 mg/h iv for 24 h after PCI

No agent

IH;6 m

Ota et al. [18]

2006

4.05/3.86

63/27

1–2 mg ic or 1–2 mg ic + 4 mg bolus iv, 6 mg/h iv(total:96 mg)

No agent

IH

Pi et al. [19]

2019

6.51/6.86

95/45

a:4 mg ic, 4 mg/h iv for 24 h

b:4 mg ic,saline 4 ml/h iv for 24 h

Saline:8 ml ic, 4 ml/h iv for 24 h

IH

Qi et al. [20]

2018

5.7/6.1

40/80

2 mg ic

Nitroprusside:200 μg ic or saline only

IH;3 m

Wang et al. [21]

2017

4.8/4.5/3.8*

53/105

6 mg ic

NG 300 μg ic or no agent

IH;3 m

Wang et al. [24]

2020

5.9/5.7

59/60

iv, dosage not mentioned

No agent

6 m

Yamada et al. [22]

2015

6.4/6.8

28/24

0.2 mg/kg ic before the initial and final angiograms;2.0 mg/h iv for 4 days

Nitroglycerin 0.2 mg/kg ic before the initial and final angiograms;2.0 mg/h iv for 4 days

IH

  1. Ic, intracoronary; IH, in hospital; iv, intravenous; N/C, nicorandil/control groups; po, per oral
  2. *Median